Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
affordable care act
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
detroit blog main
detroit top stories
indiana blog main
indiana top stories
merck
national
national blog main
national top stories
new york blog main
new york top stories
pembrolizumab
3
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abeona therapeutics
agios pharmaceuticals
alirocuma
alzheimer's
ameet nathwani
arches
biotech
david schenkein
debate
digital
donald trump
What
bio
nash
3
×
roundup
american
based
best
continue
crash
debate
healthcare
industry
kind
people
pharmaceutical
policy
politicians
pressure
scalps
trump’s
u.s
approval
biogen’s
biopharmaceutical
companies
convo
drug
earlier
failures
littered
new
news
price
remains
road
strategy
talk
Language
Current search:
nash
×
pembrolizumab
×
@xconomy.com
4 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
